Since 2011, we have rapidly emerged as a leader in multiple sclerosis (MS), an often disabling disease of the central nervous system affecting more than 2.3 million people worldwide.
MS is a chronic disease that affects each person differently, with symptoms ranging from numbness in the limbs or forgetfulness to paralysis or loss of vision. MS is caused when the body’s immune system attacks the central nervous system, damaging the myelin sheath—the protective layer covering the nerves that carry signals between the brain and spinal cord and the rest of the body.
For over a decade, we have been working to develop novel treatments for MS. With two products currently in our MS franchise, we’re committed to maintaining long-term partnerships with patients, physicians, advocates, and researchers and making a significant impact on the unmet needs of those living with MS.
Learn about treatment options for relapsing MS
A future focusing on repair
Our research and development efforts remain focused in areas where we believe we have the strongest potential to help patients in need. This includes early-stage programs on preventing and repairing the damage to the nervous system caused by MS.
Inspired by patients around the world
Above from left to right: Anita, multiple sclerosis, France; Cassie, multiple sclerosis, Australia; Dave, multiple sclerosis, United Kingdom